InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,077.20
(
1.94%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.57
(
1.34%
)
Bitcoin
66,338.96
(
-0.78%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

curestation

Send PM Follow Ignore
Followers 1
Posts 50
Boards Moderated 0
Alias Born 07/24/2015

curestation

Re: Buddhahead post# 23342

Friday, 07/24/2015 12:00:44 PM

Friday, July 24, 2015 12:00:44 PM

Post# of 30990
Buddha- the offering is safe. They triggered a Nasdaq requirement because the warrant pricing was incorrect. Mistake. Positive results from the UK will get the interest of potential partners. The trials are meant to confirm what the scientists already know: Antabine controls inflammation. Dosage and mode of delivery are two keys. With the market cap at $10M there's not much risk to partner up with Rock Creek...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up